Profile	GDS4460 / 211430_s_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	2586.9	98
GSM803589	patient 7, baseline	994.8	95
GSM803592	patient 8, baseline	1252.6	96
GSM803595	patient 10, baseline	110.9	68
GSM803598	patient 11, baseline	29.1	48
GSM803601	patient 12, baseline	141.4	73
GSM803604	patient 13, baseline	6970.4	99
GSM803607	patient 14, baseline	2717.6	98
GSM803610	patient 15, baseline	170.7	77
GSM803613	patient 16, baseline	137.2	74
GSM803587	patient 6, arm treated with pimecrolimus	163.5	76
GSM803590	patient 7, arm treated with pimecrolimus	3559.6	99
GSM803593	patient 8, arm treated with pimecrolimus	2119.5	98
GSM803605	patient 13, arm treated with pimecrolimus	11334.9	99
GSM803608	patient 14, arm treated with pimecrolimus	1116.4	96
GSM803599	patient 11, arm treated with pimecrolimus	72.7	63
GSM803611	patient 15, arm treated with pimecrolimus	48.7	56
GSM803614	patient 16, arm treated with pimecrolimus	222	80
GSM803602	patient 12, arm treated with pimecrolimus	185	78
GSM803596	patient 10, arm treated with pimecrolimus	100.3	67
GSM803591	patient 8, arm treated with betamethasone	226.7	81
GSM803609	patient 15, arm treated with betamethasone	929.8	95
GSM803597	patient 11, arm treated with betamethasone	551.2	91
GSM803585	patient 6, arm treated with betamethasone	138.8	73
GSM803603	patient 13, arm treated with betamethasone	16833.2	100
GSM803612	patient 16, arm treated with betamethasone	916.3	95
GSM803588	patient 7, arm treated with betamethasone	1334.6	97
GSM803594	patient 10, arm treated with betamethasone	222.4	80
GSM803600	patient 12, arm treated with betamethasone	274.4	83
GSM803606	patient 14, arm treated with betamethasone	690.6	93